Dr Patel on the FDA Approval of Ide-Cel for Triple Class

Krina K. Patel, MD, MSc, discusses the FDA approval of ide-cel for patients with triple class–exposed relapsed/refractory multiple myeloma.

Related Keywords

Texas , United States , Krinak Patel , , Department Of Lymphoma Myeloma , University Of Texas Md Anderson Cancer Center , Division Of Cancer Medicine , Cancer Medicine , Cancer Center , D , Sc , Fda Approval Of Ide Cel , Patients With Triple Class Exposed Relapsed Refractory Multiple Myeloma ,